soul trial oral semaglutide cardiovascular outcomes 2024 results nejm A emulation in Nature Medicine shows that treatment with and tirzepatide showed similar levels of benefit on in people at elevated cardiovascular risk with obesity and diabetes. Link Trial Scorecard: SOUL

Patients are embarrassed to raise it, so partners and co-workers notice before clinicians do, Mr

(Class I, level C) Additional learning points: Do you know the difference between opportunistic and systematic CVD screening

Replacing carbohydrates with poly or monounsaturated fats can help in the reduction of triglycerides and promotion of good cholesterol

This slowing effect can also promote weight loss by prolonging the sensation of fullness

Real-world use of once-weekly semaglutide in patients with type 2 diabetes: Results from the SURE Denmark/Sweden multicentre, prospective, observational study

GLP-1 is the natural hormone